These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 16272363)
1. Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. Colombara M; Antonini V; Riviera AP; Mainiero F; Strippoli R; Merola M; Fracasso G; Poffe O; Brutti N; Tridente G; Colombatti M; Ramarli D J Immunol; 2005 Nov; 175(10):7021-8. PubMed ID: 16272363 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia. Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672 [TBL] [Abstract][Full Text] [Related]
3. Thymic and peripheral blood T- and B-cell levels in myasthenia gravis. Lisak RP; Zweiman B; Phillips SM Neurology; 1978 Dec; 28(12):1298-301. PubMed ID: 310526 [TBL] [Abstract][Full Text] [Related]
4. p38 MAPK is a critical regulator of the constitutive and the beta4 integrin-regulated expression of IL-6 in human normal thymic epithelial cells. Mainiero F; Colombara M; Antonini V; Strippoli R; Merola M; Poffe O; Tridente G; Ramarli D Eur J Immunol; 2003 Nov; 33(11):3038-48. PubMed ID: 14579272 [TBL] [Abstract][Full Text] [Related]
5. Central role of interferon-beta in thymic events leading to myasthenia gravis. Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484 [TBL] [Abstract][Full Text] [Related]
6. Thymic lymphocytes in myasthenia gravis. Birnbaum G; Tsairis P Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518 [TBL] [Abstract][Full Text] [Related]
8. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis. Namba T; Nakata Y; Grob D Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115 [TBL] [Abstract][Full Text] [Related]
9. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy. Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases. Amrani Y; Ammit AJ; Panettieri RA Mol Pharmacol; 2001 Oct; 60(4):646-55. PubMed ID: 11562425 [TBL] [Abstract][Full Text] [Related]
11. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma. Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711 [TBL] [Abstract][Full Text] [Related]
12. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. Kujime K; Hashimoto S; Gon Y; Shimizu K; Horie T J Immunol; 2000 Mar; 164(6):3222-8. PubMed ID: 10706714 [TBL] [Abstract][Full Text] [Related]
13. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489 [TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. Aarli JA; Heimann P; Matre R; Thunold S; Tönder O J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870 [TBL] [Abstract][Full Text] [Related]
15. Diesel exhaust particles activate p38 MAP kinase to produce interleukin 8 and RANTES by human bronchial epithelial cells and N-acetylcysteine attenuates p38 MAP kinase activation. Hashimoto S; Gon Y; Takeshita I; Matsumoto K; Jibiki I; Takizawa H; Kudoh S; Horie T Am J Respir Crit Care Med; 2000 Jan; 161(1):280-5. PubMed ID: 10619832 [TBL] [Abstract][Full Text] [Related]
16. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Bérubé J; Bourdon C; Yao Y; Rousseau S Cell Signal; 2009 Mar; 21(3):448-56. PubMed ID: 19121387 [TBL] [Abstract][Full Text] [Related]
17. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells. Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Kujime K; Hayashi S; Takeshita I; Horie T Clin Exp Allergy; 2000 Jan; 30(1):48-55. PubMed ID: 10606930 [TBL] [Abstract][Full Text] [Related]
18. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324 [TBL] [Abstract][Full Text] [Related]
19. B-cell compartment in the thymus of patients with myasthenia gravis and control subjects. Christensson B; Biberfeld P; Matell G Ann N Y Acad Sci; 1988; 540():293-7. PubMed ID: 3264672 [TBL] [Abstract][Full Text] [Related]